Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Argus Health
Covington
Teva
Mallinckrodt
Fish and Richardson
UBS
US Department of Justice
Fuji
Chinese Patent Office

Generated: August 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075201

« Back to Dashboard
NDA 075201 describes INDAPAMIDE, which is a drug marketed by Amerigen Pharms Ltd, Mylan Pharms Inc, Actavis Elizabeth, Mylan, Teva, Watson Labs, Sandoz, and Ani Pharms Inc, and is included in nine NDAs. It is available from ten suppliers. Additional details are available on the INDAPAMIDE profile page.

The generic ingredient in INDAPAMIDE is indapamide. There are seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the indapamide profile page.

Summary for NDA: 075201

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 075201

Physiological EffectIncreased Diuresis

Suppliers and Packaging for NDA: 075201

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
INDAPAMIDE
indapamide
TABLET;ORAL 075201 ANDA Amerigen Pharmaceuticals Inc. 43975-217 43975-217-10 100 TABLET in 1 BOTTLE (43975-217-10)
INDAPAMIDE
indapamide
TABLET;ORAL 075201 ANDA Amerigen Pharmaceuticals Inc. 43975-217 43975-217-11 1000 TABLET in 1 BOTTLE (43975-217-11)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1.25MG
Approval Date:Dec 4, 1998TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Dec 4, 1998TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Julphar
McKinsey
Express Scripts
QuintilesIMS
Daiichi Sankyo
Accenture
Covington
Moodys
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot